SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001178913-23-000164
Filing Date
2023-01-13
Accepted
2023-01-13 16:02:01
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-1 zk2329008.htm S-1 805343
2 EXHIBIT 4.1 exhibit_4-1.htm EX-4.1 353341
3 EXHIBIT 10.9 exhibit_10-9.htm EX-10.9 72979
4 EXHIBIT 10.10 exhibit_10-10.htm EX-10.10 76384
5 EXHIBIT 10.11 exhibit_10-11.htm EX-10.11 136789
6 EXHIBIT 21.1 exhibit_21-1.htm EX-21.1 5809
7 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 2221
8 FILING FEES TABLE exhibit_107.htm EX-FILING FEES 42649
9 image1.jpg GRAPHIC 101423
10 image2.jpg GRAPHIC 88632
  Complete submission text file 0001178913-23-000164.txt   1758441
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-269218 | Film No.: 23528694
SIC: 2834 Pharmaceutical Preparations